Other Therapy Forms
The two standard clinical therapies used for hair loss in men, and to some degree women (minoxidil and finasteride), have not been proven to improve the metabolism of follicular proteoglycans and are therefore not appropriate options for the clinical treatment of Proteoglycan Follicular Atrophy.
Among the unwanted side effects in women, in addition to increased blood pressure, is Hypertrichosis. This manifests itself as excessive hair growth all over the body or isolated to small patches like a beard or sideburns which are naturally unwanted by most women.
Finasteride should generally not be used in women especially during pregnancy or breast-feeding, as it may harm an unborn or breast-feeding baby.
Furthermore, a meta-analysis of clinical trials found that anti-androgen drugs, including finasteride, to be no more effective than placebo in women with Female Pattern Hair Loss – meaning that in principle it shows no effect whatsoever.
This is often done at a disproportionately large cost and not providing any real or proper lasting clinical results.
Vitamin B derivatives are a major part of these. Contrary to widespread belief, it is very rare to be deficient of general vitamins or minerals. In fact, less than 2% of hair growth issues and/or hair loss is due to this. There is unfortunately, however, a misconception among professionals and users alike that products containing vitamin B derivatives are important for hair growth and quality.
The fact is that through a meta-analysis of clinical studies on vitamin B products, our colleagues have documented and published that, existing major hair vitamins B products work no better than placebo – meaning that in principle it shows no effect whatsoever.
Therefore, so-called hair vitamins are not recommended as a clinical solution for increasing results no matter how presentable the packaging might seem or the status of the celebrity endorsing them might be.